Nevertheless, we found that 10 patients with GSD-Ib were diagnosed with GSD-associated IBD after receiving G-CSF therapy, suggesting that G-CSF administration could not prevent and treat GSD-associated IBD. This evidence concerns the gene CSF3 and disorder of glycogen metabolism.